Bozor kapitallashuvining balans qiymatiga nisbati: Coherus Biosciences (CHRS)

Coherus BioSciences Inc. (CHRS) korporativ emblemasi va logotipi

Coherus Biosciences (CHRS) narxlarining dinamikasi biosimilar ta'minotining barqarorligi uchun sovuq zanjir optimallashtirish samaradorligini ko'rsatadi, bunda ko'rsatkich 3.03 darajasida turibdi. Coherus Biosciences o'smalarga qarshi kurashish uchun shaxsiy immunoterapiya ishlanmalarini joriy etish orqali o'z biznesini transformatsiya qilmoqda. Coherus Biosciences ning raqobatbardoshligi zamonaviy davolash xarajatlarini kamaytirishga asoslangan bo'lib, bu agressiv tijorat targ'iboti bilan birgalikda rivojlanish modelini juda istiqbolli qiladi.

Coherus (CHRS) - Bozor qiymatining balans qiymatiga koeffitsiyenti 04.07.2022dan 29.10.2026gacha
Coherus BioSciences yetakchi tovari

Coherus Biosciences (CHRS) kompaniyasida narxlarning bosimi va pul oqimi tebranishlari fonida biosimilarlarni joriy etishning o'ziga xos xususiyatlari aktivlarning haqiqiy qiymatini kuzatishni o'ta muhim qiladi. Buxgalteriya qiymatiga nisbatan narx koeffitsiyentini tahlil qilish orqali investor bozor baholovishining buxgalteriya qiymatidan yuqori ekanligini baholaydi, bunda koeffitsiyentning o'sishi moliyaviy barqarorlikni tasdiqlasa, uning pasayishi qarz yukining ortishi bilan bog'liq xatarlardan signal beradi.

Raqobatchilar tahlili

Incyte Corporation (INCY) - Bozor qiymatining balans qiymatiga nisbati|HCM - Balans qiymatiga nisbatan bozor kapitallashuvi|NUVB (Nuvation Bio) - Bozor kapitallashuvining balans qiymatiga nisbati|DAWN - Bozor qiymatining xususiy kapitalga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati MNPR|INBX - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati I-Mab Biopharma IMAB|FENC: Kapitallashuvning balans qiymatiga nisbati|Heron Therapeutics Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Nuvectis Pharma Inc.|Corbus Pharma (CRBP) - Bozor qiymatining balans qiymatiga nisbati|Cardiff Oncology - Balans qiymatiga nisbatan bozor qiymati|BYSI (BeyondSpring Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati BioAtla Corp|Bozor qiymatining balans qiymatiga nisbati Lixte Biotechnology Holdings, Inc. (LIXT)|Bozor qiymatining balans qiymatiga nisbati CTXR (citiuspharma.com)|Cellectar - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati BLRX|CANF - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Aprea Therapeutics|kaziatherapeutics.com (KZIA) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati SLXN|NCNA (NuCana PLC) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Chimerix Inc (CMRX)|Bozor qiymatining balans qiymatiga nisbati Cyclacel Pharmaceuticals (CYCC)|GTHX - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Kronos Bio KRON|Kintara Therapeutics Inc - Bozor qiymatining balans qiymatiga nisbati|ONCT - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Portage Biotech Corp